Topological Causal Effects
Organizations: Department of Statistics, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea
Abstract
Estimating causal effects is particularly challenging when outcomes arise in complex, non-Euclidean spaces, where conventional methods often fail to capture meaningful structural variation. We develop a framework for topological causal inference that defines treatment effects through differences in the topological structure of potential outcomes, summarized by power-weighted silhouette functions of persistence diagrams. We develop an efficient, doubly robust estimator in a fully nonparametric model, establish functional weak convergence, and construct a formal test of the null hypothesis of no topological effect. Empirical studies illustrate that the proposed method reliably quantifies topological treatment effects across diverse complex outcome types.
Figures & tables
Appendix figures & tables11 assets
Supplementary material from the paper’s appendix.
Appendix
| SARS-CoV-2 | GEOM-Drugs | ORBIT | ||||||||
| dist. | Std. | dist. | Std. | dist. | Std. | dist. | Std. | dist. | Std. | |
| PI | 4.544 | 2.712 | 3.215 | 0.740 | 7.041 | 1.283 | 0.571 | 0.530 | 36.063 | 37.704 |
| IPW | 2.936 | 9.035 | 1.670 | 5.756 | 18.886 | 8.337 | 0.073 | 3.722 | 18.210 | 93.978 |
| AIPW | 1.246 | 3.099 | 3.296 | 1.470 | 2.136 | 1.553 | 0.121 | 0.802 | 6.920 | 47.127 |
| Data (Sample Size) | SARS-CoV-2 (2481) | GEOM-Drugs (30433) | ORBIT (2000) |
| Runtime | 244 seconds | 21 second | 25 seconds |
| SARS-CoV-2 ( ) | is misspecified, is correct | is misspecified, is correct | ||
| dist. | Std. | dist. | Std. | |
| PI | 1.390 | 3.132 | 7.985 | 3.132 |
| IPW | 9.674 | 4.421 | 2.243 | 4.328 |
| AIPW | 0.786 | 2.761 | 1.529 | 3.395 |